AI Governance in Medical Imaging: The Invisible Layer

The convergence of AI and medical imaging isn't just accelerating. it's formalizing. With the 2026 ACR-SIIM Practice Parameter pushing for local acceptance testing and continuous drift monitoring, the infrastructure of AI governance in this sector is getting a facelift. The ACR Assess-AI registry is already keeping tabs on AI outputs using DICOM metadata, providing context. But there's a looming blind spot that needs illumination.

The Unseen Variable

Current protocols might be missing a important layer: the integrity of incoming studies within the acquisition envelope on which models were validated. This isn't just a technicality, it's the bedrock of reliable AI application. Consider the case of a MONAI RetinaNet lung-nodule detector trained on LUNA16 data. When tested on identical CT images with differing reconstruction kernels (NLST B30f vs B80f), the kernel alone changed the AI-measured diameter, flipping a size category in 5.2% of nodules without affecting detection confidence.

What's the implication? AI's performance might falter if the incoming data strays from its training parameters. This poses a fundamental challenge for diagnostic accuracy. If the AI-AI Venn diagram is getting thicker, then so too should our scrutiny of these unseen variables.

Mapping AI's Weak Points

The study revealed that acquisition states map to AI failure modes. Frequency content impacts measurement reliability, while noise affects detection sensitivity. The kicker? These aren't recoverable from metadata alone. A 4-feature pixel fingerprint, however, can recover reconstruction identity with high accuracy (patient-level AUC of about 0.95 on real CTs). This suggests that metadata like the ConvolutionKernel DICOM tag falls short, offering identical labels across reconstructions.

The cross-manufacturer analysis further underscores the point. The kernel axis consistently transported across four vendors, achieving leave-one-vendor-out AUC values between 0.94 and 0.98. It matched the within-vendor ceiling, emphasizing that acquisition-aware validation is the missing layer in AI's imaging governance. Without it, are we truly accrediting AI correctly?

The Road Ahead

As AI governance frameworks evolve, it's imperative to integrate acquisition-aware, input-side validation into the acceptance-testing and drift-monitoring regimes. We're building the financial plumbing for machines, and this plumbing needs to be reliable enough to sustain the intricate demands of medical imaging.

If agents have wallets, who holds the keys? The question is particularly poignant in medical AI. To ensure that AI tools in radiology are both precise and valid, institutions must address this acquisition layer. It's a vital step in ensuring that AI not only serves but enhances the healthcare system's capacity to diagnose and treat patients effectively.